Rising Adoption of OCT Devices in Retinal Disease Diagnostics to Boost Market Growth

Optical Coherence Tomography Devices market 


The Optical Coherence Tomography Devices Market is estimated to be valued at US$ 1.7 Bn in 2023 and is expected to exhibit a CAGR of 15.57% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Optical coherence tomography (OCT) devices utilize light waves and low-coherence interferometry to generate high-resolution, three-dimensional cross-sectional images of internal ocular structures including the retina, optic disc and macula. OCT helps ophthalmologists evaluate various retinal and optic nerve conditions. Major applications of OCT devices include diagnosis and management of retinal diseases like macular edema, macular hole, glaucoma and age-related macular degeneration.


Market Dynamics:


The OCT devices market is driven by increasing occurrence of retinal diseases due to growing geriatric population base and rising adoption of OCT devices in diagnostic procedures. According to WHO, globally around 1.1 billion people are projected to have some form of vision impairment by 2050, with vision impairment due to retinal diseases accounting for majority of cases. Furthermore, continuous technological advancements for development of high-resolution OCT devices with artificial intelligence integration for automated image analysis is further expected to bolster the market growth over the forecast period.

Market key trends:


The Optical Coherence Tomography Devices market has been witnessing high adoption of portable OCT devices. Portable OCT devices are gaining significant traction as they offer advantages such as convenience of use at the point-of-care and ability to perform OCT scans in remote locations. Furthermore, technological advancements such as increased imaging speed and resolution have increased the utility of OCT devices across various medical specialties including ophthalmology, cardiology, dentistry and dermatology.


SWOT Analysis


Strengths: High resolution 3D imaging capability without contact or dyes. Non-invasive procedure.
Weaknesses: High cost of devices. Lack of skilled professionals to operate high-end OCT devices.
Opportunities: Increasing applications in disease diagnosis and treatment monitoring. Growing demand for portable OCT devices.
Threats: Strong presence of alternative eye examination technologies. Stiff competition among existing market players.


Key Takeaways


The Global Optical Coherence Tomography Devices Market Size is expected to witness high growth, exhibiting CAGR of 15.57% over the forecast period, due to increasing prevalence of chronic eye diseases and rising demand for non-invasive diagnostic procedures. The market was valued at US$ 1.7 billion in 2023.

Regional analysis: North America dominates the global Optical Coherence Tomography Devices market supported by rising healthcare expenditures and technological advancements in ophthalmology. Asia Pacific is expected to witness fastest growth over the forecast period due to growing medical tourism industry and increasing patient pool of eye diseases.

Key players: Key players operating in the Optical Coherence Tomography Devices market are Carl Zeiss Meditec AG, Leica Microsystems, Bausch Health Companies Inc., Teledyne UK Limited, Michelson Diagnostics Ltd, SCHWIND eye-tech-solutions, Wasatch Photonics, Enhanced Medical Services, Optovue, Incorporated and Ibsen Photonics A/S. These players are focusing on new product launches and geographic expansion to gain a competitive edge in the market.



Read More -  https://www.insightprobing.com/optical-coherence-tomography-devices-market-share-growth-analysis-size-trends-and-forecasts/


 

Comments

Post a Comment

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Image
   Windsurf Foil Board Market In the exhilarating world of water sports, the Windsurf Foil Board Market emerges as a key player, offering enthusiasts innovative equipment to enhance their riding experience. As this niche market continues to gain traction among windsurfing aficionados worldwide, it undergoes significant shifts influenced by various drivers, challenges, and geographical nuances. The Windsurf Foil Board Market size was valued at  US$ 167.4 Mn in 2024  and is expected to reach  US$ 268.6 Mn by 2031 , growing at a compound annual growth rate  (CAGR) of 7% from 2024 to 2031 Key Takeaways A prominent trend in the Windsurf Foil Board Market Demand is the increasing adoption of foil technology. Foil boards, equipped with hydrofoils beneath the waterline, enable riders to glide effortlessly above the water's surface, providing a thrilling and dynamic experience. This technological innovation has revolutionized the windsurfing landscape, attrac...
Read more

Idiopathic Hypersomnia Treatment Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Idiopathic Hypersomnia

Image
  Idiopathic Hypersomnia Treatment Market Idiopathic hypersomnia is a neurological sleep disorder characterized by excessive daytime sleepiness and long periods of sleep that does not improve even after long sleep. The treatment of idiopathic hypersomnia is done through medication and behavioral therapies. Medications like psychostimulants, serotonin modulators, wakefulness promoting agents are used to treat the condition and increase wakefulness. The increasing prevalence of idiopathic hypersomnia due to genetic and environmental factors is expected to drive the growth of the idiopathic hypersomnia treatment market. The Global Idiopathic Hypersomnia Treatment Market is estimated to be valued at US$ 389.86 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the Idiopathic Hypersomnia Treatment Market are Esaote SPA, Epica Animal Health, IDEXX Laboratories, Carestream Health, IMV Imaging, Fujifilm Hold...
Read more

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Image
  Niemann-Pick Disease Drug Type C Treatment Market Key Takeaways The Niemann-Pick Disease Drug Type C Treatment Market is witnessing significant growth, driven by advancements in medical research and a deeper understanding of the disease pathology. Niemann-Pick Disease Type C (NPC) is a rare genetic disorder characterized by the accumulation of cholesterol and other lipids within cells, leading to progressive neurological and visceral symptoms. With an increasing focus on rare diseases and orphan drug development, the market for NPC treatment is expanding rapidly, offering hope to patients and caregivers. Key players in the pharmaceutical industry are actively investing in research and development to bring novel therapies to market, underscoring the potential for transformative interventions in NPC management. Global Niemann-Pick Disease Drug Type C Treatment Market is estimated to be valued at  US$ 45.40  million  in 2024, and is expected to exhibit a  CAG...
Read more